Foretinib is a potent inhibitor of oncogenic ROS1 fusion proteins

Monika A. Davare, Anna Saborowski, Christopher A. Eide, Cristina Tognon, Rebecca L. Smith, Johannes Elferich, Anupriya Agarwal, Jeffrey W. Tyner, Ujwal P. Shinde, Scott W. Lowe, Brian J. Druker

Research output: Contribution to journalArticlepeer-review

96 Scopus citations

Fingerprint

Dive into the research topics of 'Foretinib is a potent inhibitor of oncogenic ROS1 fusion proteins'. Together they form a unique fingerprint.

Medicine & Life Sciences